Story perspectives

Revolutionary Cancer Treatment Targets Tumor's Matrix for Hope

9/4/2025

Summary

Story summary

Cambridge researchers are developing a cancer treatment that targets the tumor's extracellular matrix instead of the cells directly.
This therapy aims to reprogram cancer cells, potentially slowing the growth of solid tumors such as glioblastoma.
The method may work for various tumors without needing drugs to reach every cancer cell.
Animal model experiments will evaluate the therapy's effectiveness before clinical trials.
Key challenges include safe delivery of treatments to alter hyaluronic acid in the brain and ensuring lasting effects against tumor recurrence.

1 of 1

Story summary

Cambridge researchers are developing a cancer treatment that targets the tumor's extracellular matrix instead of the cells directly.
This therapy aims to reprogram cancer cells, potentially slowing the growth of solid tumors such as glioblastoma.
The method may work for various tumors without needing drugs to reach every cancer cell.
Animal model experiments will evaluate the therapy's effectiveness before clinical trials.
Key challenges include safe delivery of treatments to alter hyaluronic acid in the brain and ensuring lasting effects against tumor recurrence.